Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients

NCT01822080 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Dienogest (Visanne, BAY86-5258)
DRUG: Placebo

Sponsor

Bayer